Hashem E El-Serag (Hashem B El-Serag, Hashem El-Serag, Hashem B El Serag)

ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 35

Top Venues

Digestive diseases and sciences

Gut

Hepatology (Baltimore, Md.)

Nature reviews. Gastroenterology & hepatology

Baylor College of Medicine

Al-Arab Medical University (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Baylor College of Medicine Jan 01 2017

United States

Chairman, Department of Medicine :: Medicine

Education History

Al-Arab Medical University

Libya

PHD

Publications

Aaron P Thrift, Theresa H Nguyen Wenker, Kyler Godwin, Maya Balakrishnan, Hao T Duong, Rohit Loomba, Fasiha Kanwal, Hashem E El-Serag
An Electronic Health Record Model for Predicting Risk of Hepatic Fibrosis in Primary Care Patients. Digestive diseases and sciences (2024)
Mario J Dinis-Ribeiro, Shailja C Shah, Hashem E El-Serag, Matthew Banks, Noriya Uedo, Hisao Tajiri, Luiz Gonzaga Vaz Coelho, Diogo Libânio, Edith Lahner, Antonio Rollan, Jing-Yuan Fang, Leticia Moreira, Jan Bornschein, Peter Malfertheiner, Ernst J Kuipers, Emad M El-Omar
The road to a world-unified approach to the management of patients with gastric intestinal metaplasia: a review of current guidelines. Gut (2024)
Aaron P Thrift, Theresa H Nguyen Wenker, Kyler Godwin, Maya Balakrishnan, Hao T Duong, Rohit Loomba, Fasiha Kanwal, Hashem E El-Serag
An Electronic Health Record Model for Predicting Risk of Hepatic Fibrosis in Primary Care Patients. Digestive diseases and sciences 69 (7) (2024)
Aaron P Thrift, Theresa H Nguyen Wenker, Kyler Godwin, Maya Balakrishnan, Hao T Duong, Rohit Loomba, Fasiha Kanwal, Hashem E El-Serag
An Electronic Health Record Model for Predicting Risk of Hepatic Fibrosis in Primary Care Patients. Digestive diseases and sciences 69 (7) (2024)
Hannah Powell, Cristian Coarfa, Elisa Ruiz-Echartea, Sandra L Grimm, Omar Najjar, Bing Yu, Luis Olivares, Michael E Scheurer, Christie Ballantyne, Abeer Alsarraj, Emad Mohamed Salem, Aaron P Thrift, Hashem E El-Serag, Salma Kaochar
Differences in Prediagnostic Serum Metabolomic and Lipidomic Profiles Between Cirrhosis Patients with and without Incident Hepatocellular Carcinoma. Journal of hepatocellular carcinoma 11 (2024)
Aaron P Thrift, Theresa H Nguyen Wenker, Kyler Godwin, Maya Balakrishnan, Hao T Duong, Rohit Loomba, Fasiha Kanwal, Hashem E El-Serag
An Electronic Health Record Model for Predicting Risk of Hepatic Fibrosis in Primary Care Patients. Digestive diseases and sciences 69 (7) (2024)
Hashem E El-Serag, Fasiha Kanwal, Jing Ning, Hannah Powell, Saira Khaderi, Amit G Singal, Sumeet Asrani, Jorge A Marrero, Christopher I Amos, Aaron P Thrift, Michelle Luster, Abeer Alsarraj, Luis Olivares, Darlene Skapura, Jenny Deng, Emad Salem, Omar Najjar, Xian Yu, Hao Duong, Michael E Scheurer, Christie M Ballantyne, Salma Kaochar
Serum biomarker signature is predictive of the risk of hepatocellular cancer in patients with cirrhosis. Gut (2024)
Aaron P Thrift, Theresa H Nguyen Wenker, Kyler Godwin, Maya Balakrishnan, Hao T Duong, Rohit Loomba, Fasiha Kanwal, Hashem E El-Serag
An Electronic Health Record Model for Predicting Risk of Hepatic Fibrosis in Primary Care Patients. Digestive diseases and sciences (2024)
Hashem E El-Serag, Fasiha Kanwal, Jing Ning, Hannah Powell, Saira Khaderi, Amit G Singal, Sumeet Asrani, Jorge A Marrero, Christopher I Amos, Aaron P Thrift, Michelle Luster, Abeer Alsarraj, Luis Olivares, Darlene Skapura, Jenny Deng, Emad Salem, Omar Najjar, Xian Yu, Hao Duong, Michael E Scheurer, Christie M Ballantyne, Salma Kaochar
Serum biomarker signature is predictive of the risk of hepatocellular cancer in patients with cirrhosis. Gut (2024)
Hashem E El-Serag, Fasiha Kanwal, Jing Ning, Hannah Powell, Saira Khaderi, Amit G Singal, Sumeet Asrani, Jorge A Marrero, Christopher I Amos, Aaron P Thrift, Michelle Luster, Abeer Alsarraj, Luis Olivares, Darlene Skapura, Jenny Deng, Emad Salem, Omar Najjar, Xian Yu, Hao Duong, Michael E Scheurer, Christie M Ballantyne, Salma Kaochar
Serum biomarker signature is predictive of the risk of hepatocellular cancer in patients with cirrhosis. Gut (2024)
Hashem E El-Serag, Qingchun Jin, Nabihah Tayob, Emad Salem, Michelle Luster, Abeer Alsarraj, Saira Khaderi, Amit G Singal, Jorge A Marrero, Sumeet K Asrani, Fasiha Kanwal
HES V2.0 outperforms GALAD for detection of HCC: A phase 3 biomarker study in the United States. Hepatology (Baltimore, Md.) (2024)
Hashem E El-Serag, Fasiha Kanwal, Jing Ning, Hannah Powell, Saira Khaderi, Amit G Singal, Sumeet Asrani, Jorge A Marrero, Christopher I Amos, Aaron P Thrift, Michelle Luster, Abeer Alsarraj, Luis Olivares, Darlene Skapura, Jenny Deng, Emad Salem, Omar Najjar, Xian Yu, Hao Duong, Michael E Scheurer, Christie M Ballantyne, Salma Kaochar
Serum biomarker signature is predictive of the risk of hepatocellular cancer in patients with cirrhosis. Gut (2024)
Hashem E El-Serag, Fasiha Kanwal, Jing Ning, Hannah Powell, Saira Khaderi, Amit G Singal, Sumeet Asrani, Jorge A Marrero, Christopher I Amos, Aaron P Thrift, Michelle Luster, Abeer Alsarraj, Luis Olivares, Darlene Skapura, Jenny Deng, Emad Salem, Omar Najjar, Xian Yu, Hao Duong, Michael E Scheurer, Christie M Ballantyne, Salma Kaochar
Serum biomarker signature is predictive of the risk of hepatocellular cancer in patients with cirrhosis. Gut (2024)
Hashem E El-Serag, Qingchun Jin, Nabihah Tayob, Emad Salem, Michelle Luster, Abeer Alsarraj, Saira Khaderi, Amit G Singal, Jorge A Marrero, Sumeet K Asrani, Fasiha Kanwal
HES V2.0 outperforms GALAD for detection of HCC: A phase 3 biomarker study in the United States. Hepatology (Baltimore, Md.) (2024)
Hashem E El-Serag, Fasiha Kanwal, Jing Ning, Hannah Powell, Saira Khaderi, Amit G Singal, Sumeet Asrani, Jorge A Marrero, Christopher I Amos, Aaron P Thrift, Michelle Luster, Abeer Alsarraj, Luis Olivares, Darlene Skapura, Jenny Deng, Emad Salem, Omar Najjar, Xian Yu, Hao Duong, Michael E Scheurer, Christie M Ballantyne, Salma Kaochar
Serum biomarker signature is predictive of the risk of hepatocellular cancer in patients with cirrhosis. Gut (2024)
Sharon Pan, Aaron P Thrift, Ghida Akhdar, Hashem E El-Serag
Gastric Cancer Risk in Patients with Long-Term Use of Proton Pump Inhibitors: A Systematic Review and Meta-Analysis of Observational and Interventional Studies. Digestive diseases and sciences (2023)
Hashem E El-Serag, Ghida Akhdar, Aaron P Thrift, Michelle Luster, Saira Khaderi, Abeer Alsarraj, Hao Duong, Fasiha Kanwal
Bioimpedance analysis predicts the etiology of cirrhosis in a prospective cohort study. Hepatology communications 7 (10) (2023)
Aaron P Thrift, Theresa Nguyen Wenker, Hashem E El-Serag
Global burden of gastric cancer: epidemiological trends, risk factors, screening and prevention. Nature reviews. Clinical oncology (2023)
Josep M Llovet, Catherine E Willoughby, Amit G Singal, Tim F Greten, Mathias Heikenwälder, Hashem E El-Serag, Richard S Finn, Scott L Friedman
Nonalcoholic steatohepatitis-related hepatocellular carcinoma: pathogenesis and treatment. Nature reviews. Gastroenterology & hepatology (2023)
Jennifer R Kramer, Yamini Natarajan, Jianliang Dai, Xian Yu, Liang Li, Hashem E El-Serag, Fasiha Kanwal
Reply. Hepatology (Baltimore, Md.) 76 (2) (2022)
Abiodun O Oluyomi, Kusha A Mohammadi, Hashem E El-Serag, Aaron P Thrift
Mediating Effects of Neighborhood-Level Socioeconomic Deprivation on the Association Between Race/Ethnicity and Advanced Hepatocellular Carcinoma. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 31 (7) (2022)
Mohammed Eslam, Hashem E El-Serag, Sven M Francque, Shiv Kumar Sarin, Lai Wei, Elisabetta Bugianesi, Jacob George
Metabolic (dysfunction)-associated fatty liver disease in individuals of normal weight. Nature reviews. Gastroenterology & hepatology 19 (10) (2022)
Ilvira M Khan, Donjeta Gjuka, Jingjing Jiao, Xiaoling Song, Ying Wang, Jing Wang, Peng Wei, Hashem E El-Serag, Jorge A Marrero, Laura Beretta
A Novel Biomarker Panel for the Early Detection and Risk Assessment of Hepatocellular Carcinoma in Patients with Cirrhosis. Cancer prevention research (Philadelphia, Pa.) 14 (6) (2021)
Ronnie Fass, Guy E Boeckxstaens, Hashem E El-Serag, Rachel Rosen, Daniel Sifrim, Michael F Vaezi
Gastro-oesophageal reflux disease. Nature reviews. Disease primers 7 (1) (2021)
Mark Yarchoan, Parul Agarwal, Augusto Villanueva, Shuyun Rao, Laura A Dawson, Josep M Llovet, Richard S Finn, John D Groopman, Hashem E El-Serag, Satdarshan P Monga, Xin Wei Wang, Michael Karin, Robert E Schwartz, Kenneth K Tanabe, Lewis Rowland Roberts, Preethi H Gunaratne, Allan Tsung, Kimberly A Brown, Theodore S Lawrence, Riad Salem, Amit G Singal, Amy K Kim, Atoosa Rabiee, Linda Resar, Yujin Hoshida, Aiwu Ruth He, Kalpana Ghoshal, Patrick B Ryan, Elizabeth M Jaffee, Chandan Guha, Lopa Mishra, C Norman Coleman, Mansoor M Ahmed
Recent Developments and Therapeutic Strategies against Hepatocellular Carcinoma. Cancer research 79 (17) (2020)
M Ellionore Järbrink-Sehgal, Jordan Sparkman, Alexander Damron, Marjorie M Walker, Linda K Green, Daniel G Rosen, David Y Graham, Hashem E El-Serag
Functional Dyspepsia and Duodenal Eosinophil Count and Degranulation: A Multiethnic US Veteran Cohort Study. Digestive diseases and sciences 66 (10) (2020)
Daniel Q Huang, Hashem E El-Serag, Stephen Caldwell
Global epidemiology of NAFLD-related HCC: trends, predictions, risk factors and prevention. Nature reviews. Gastroenterology & hepatology 18 (4) (2020)
Hashem E El-Serag, Rebecca Sardell, Aaron P Thrift, Fasiha Kanwal, Paige Miller
Texas Has the Highest Hepatocellular Carcinoma Incidence Rates in the USA. Digestive diseases and sciences 66 (3) (2020)
Boldbaatar Gantuya, Hashem E El-Serag, Ari Fahrial Syam
Letter: are microbes other than Helicobacter pylori associated with gastric cancer? Authors' reply. Alimentary pharmacology & therapeutics 51 (12) (2020)
Fasiha Kanwal, Jennifer R Kramer, Liang Li, Jianliang Dai, Yamini Natarajan, Xian Yu, Steven M Asch, Hashem E El-Serag
Effect of Metabolic Traits on the Risk of Cirrhosis and Hepatocellular Cancer in Nonalcoholic Fatty Liver Disease. Hepatology (Baltimore, Md.) 71 (3) (2020)
Katherine A McGlynn, Jessica L Petrick, Hashem E El-Serag
Epidemiology of Hepatocellular Carcinoma. Hepatology (Baltimore, Md.) (2020)
Boldbaatar Gantuya, Hashem E El-Serag, Takashi Matsumoto, Nadim J Ajami, Tomohisa Uchida, Khasag Oyuntsetseg, Dashdorj Bolor, Ari Fahrial Syam
Gastric mucosal microbiota in a Mongolian population with gastric cancer and precursor conditions. Alimentary pharmacology & therapeutics 51 (8) (2020)
Hashem E El-Serag, Israel C Christie, Amy Puenpatom, Diana Castillo, Fasiha Kanwal, Jennifer R Kramer
The effects of sustained virological response to direct-acting anti-viral therapy on the risk of extrahepatic manifestations of hepatitis C infection. Alimentary pharmacology & therapeutics 49 (11) (2019)
Li Jiao, Suman Maity, Cristian Coarfa, Kimal Rajapakshe, Liang Chen, Feng Jin, Vasanta Putluri, Lesley F Tinker, Qianxing Mo, Fengju Chen, Subrata Sen, Haleh Sangi-Hyghpeykar, Hashem E El-Serag, Nagireddy Putluri
A Prospective Targeted Serum Metabolomics Study of Pancreatic Cancer in Postmenopausal Women. Cancer prevention research (Philadelphia, Pa.) 12 (4) (2019)
Xiaotao Zhang, Hashem E El-Serag, Aaron P Thrift
Sex and Race Disparities in the Incidence of Hepatocellular Carcinoma in the United States Examined through Age-Period-Cohort Analysis. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 29 (1) (2019)

Hashem E El-Serag.css-eqlu8i{font-size:small;padding-left:4px;} (Hashem B El-Serag, Hashem El-Serag, Hashem B El Serag)

Publication Activity (10 Years)

Top Topics

Top Venues

Hashem E El-Serag (Hashem B El-Serag, Hashem El-Serag, Hashem B El Serag)